Regeneron Pharmaceuticals (REGN) EBT Margin (2009 - 2026)
Regeneron Pharmaceuticals (REGN) recorded EBT Margin of 35.61% in Q2 2026, down 5.71 percentage points from 41.32% a year earlier but up 12.55 percentage points from the prior quarter.
Regeneron Pharmaceuticals (REGN) EBT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Regeneron Pharmaceuticals' EBT Margin came in at 33.25% as of Jun 30, 2026, down 1.04 percentage points year-over-year; for FY2025, it was 36.47%, up 2.81 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -8.37 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 33.66% in FY2024 (+1.64 pp), 32.01% in FY2023 (-7.90 pp), 39.91% in FY2022 (-18.11 pp) and 58.03% in FY2021 (+13.18 pp).
- Quarterly EBT Margin has ranged from 22.28% in Q1 2024 to 52.61% in Q3 2021 over the past five years.
- On a year-over-year basis, EBT Margin rose in four of the last eight quarters, with an average year-over-year change of -0.27 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 11.61 percentage points in Q2 2024, against a drop of 39.32 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 23.05% (Q1 2026), 26.87% (Q4 2025) and 46.97% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -4.34% |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 35.61% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.61% |
| Mar 31, 2026 | 23.05% |
| Dec 31, 2025 | 26.87% |
| Sep 30, 2025 | 46.97% |
| Jun 30, 2025 | 41.32% |
| Mar 31, 2025 | 29.88% |
| Dec 31, 2024 | 25.29% |
| Sep 30, 2024 | 40.13% |
| Jun 30, 2024 | 45.90% |
| Mar 31, 2024 | 22.28% |
| Dec 31, 2023 | 33.42% |
| Sep 30, 2023 | 33.03% |
| Jun 30, 2023 | 34.29% |
| Mar 31, 2023 | 27.13% |
| Dec 31, 2022 | 38.80% |
| Sep 30, 2022 | 51.42% |
| Jun 30, 2022 | 33.71% |
| Mar 31, 2022 | 35.79% |
| Dec 31, 2021 | 50.56% |
| Sep 30, 2021 | 52.61% |
Regeneron Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=REGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();